PIL 0.00% 0.0¢ promisia integrative limited

Ann: GENERAL: PIL: Sales of Arthrem(R) increase by over 170%

  1. lightbulb Created with Sketch. 2
    • Release Date: 04/11/15 11:02
    • Summary: GENERAL: PIL: Sales of Arthrem(R) increase by over 170%
    • Price Sensitive: No
    • Download Document  1.21KB
    					PIL
    04/11/2015 11:02
    GENERAL
    PRICE SENSITIVE
    REL: 1102 HRS Promisia Integrative Limited
    
    GENERAL: PIL: Sales of Arthrem(R) increase by over 170%
    
    Chairman of Promisia Integrative Limited , Malcolm Johnson, announced today a
    170% increase in sales of Arthrem(R) in the 5 months to 31 October 2015
    compared with the same 5 months in the previous year. This significant
    increase in sales has occurred since the company announced, in May 2015, the
    results of its clinical trial and increased its advertising expenditure.
    
    The Company's Chief Executive Charles Daily said: "As stated in previous
    announcements, we believe this is just the beginning of accelerated sales
    growth.  When you combine a clinically proven product with an effective
    advertising campaign you are going to get increased sales."
    
    Arthrem(R) is a dietary supplement for the long-term management of symptoms
    associated with osteoarthritis. Worldwide, osteoarthritis affects
    approximately 14% of adults aged over 25 years and 34% of adults aged over 65
    years.
    
    For further information please contact:
    
    Charles Daily, Chief Executive on (04) 894 8524 or
    Malcolm Johnson, Chairman on (04) 479 3377
    
    ENDS
    End CA:00272822 For:PIL    Type:GENERAL    Time:2015-11-04 11:02:17
    				
 
watchlist Created with Sketch. Add PIL (NZSX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.